Ezetimibe and Statins on Postprandial Lipemia in Type 2 Diabetes

Inclusion Criteria: * Type 2 diabetes since at least two years * Stable metabolic control (HbA1c\<8.0%) for at least six months on diet or diet+oral hypoglycemic drugs (insulin secretagogues or metformin), not to be changed during the study period. * BMI\<30 kg/m2 and body weight stable during the last six months. * Both sexes; only post-menopausal women. * LDL-cholesterol \>130 mg/dl, plasma triglycerides \<400 mg/dl. * No use of hypolipidemic drugs in the last three months. Exclusion Criteria: * Patient with renal (serum creatinine \>1.5 mg/dl) or hepatic (serum transaminases \>three times upper normal values) impairment. * Patients with history of cardiovascular disease. * Pre-menopausal women. * Any other acute or chronic degenerative disease. * Anemia (Hb\<12 g/dl). * Uncontrolled blood pressure. * Use of any drugs able to interfere with the study medications